{Reference Type}: Journal Article
{Title}: Compliance with carbapenem guidelines in a university hospital.
{Author}: Van Hollebeke M;Chapuis C;Bernard S;Foroni L;Stahl JP;Bedouch P;Pavese P;
{Journal}: Med Mal Infect
{Volume}: 46
{Issue}: 2
{Year}: Mar 2016
{Factor}: 5.965
{DOI}: 10.1016/j.medmal.2015.10.009
{Abstract}: <B>OBJECTIVE: </B>We aimed to evaluate carbapenem prescription compliance with guidelines for nosocomial and community-acquired infections.<BR><B>METHODS: </B>We conducted a prospective study over a four-month period at our university hospital. We included all adult and pediatric hospitalized patients who had received at least one dose of carbapenem. Data was collected from patients' medical records (hard copy and computerized data; CristalLink software). Compliance with guidelines was assessed by two infectious disease specialists. Assessment criteria included indication, antibiotic choice, dosage, and treatment duration.<BR><B>RESULTS: </B>We included 152 patients in the study (65.4% of men). Carbapenem prescription was appropriate for 76.3% of prescriptions. The use of carbapenems was considered appropriate for 73.9% of empirical prescriptions and for 77.8% of documented prescriptions. Non-compliance with guidelines was mainly due to prescriptions for community-acquired infections. Antibiotic de-escalation could not be initiated in 40.3% of patients and was only initiated in 51.7% of patients for whom it could be considered. Although the average treatment duration was 7.5 days, 23.7% of patients received carbapenems for more than 10 days.<BR><B>CONCLUSIONS: </B>These results highlight the need for a strong carbapenem stewardship program in our hospital.